A phase I study of celecoxib, irinotecan and concurrent radiotherapy in the preoperative treatment of pancreatic cancer
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2010
At a glance
- Drugs Celecoxib; Irinotecan
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 01 Jul 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 29 Oct 2005 New trial record.